1. Pathogenetic profiling of COVID-19 and SARS-like viruses
- Author
-
Zulkar Nain, Matthew A. Summers, Mohammad Ali Moni, Humayan Kabir Rana, Sheikh Mohammed Shariful Islam, Pietro Liò, Lio, Pietro [0000-0002-0540-5053], and Apollo - University of Cambridge Repository
- Subjects
AcademicSubjects/SCI01060 ,Microarray ,coronavirus ,Comorbidity ,Genome, Viral ,Disease ,Biology ,comorbidities ,medicine.disease_cause ,Antiviral Agents ,03 medical and health sciences ,0302 clinical medicine ,Downregulation and upregulation ,microRNA ,Gene expression ,medicine ,Humans ,Molecular Biology ,Gene ,030304 developmental biology ,Coronavirus ,Genetics ,0303 health sciences ,Case Study ,SARS-CoV-2 ,COVID-19 ,COVID-19 Drug Treatment ,MicroRNAs ,Severe acute respiratory syndrome-related coronavirus ,Drug development ,Case-Control Studies ,030220 oncology & carcinogenesis ,2019-nCoV ,microarray ,Transcription Factors ,Information Systems - Abstract
The novel coronavirus (2019-nCoV) has recently emerged, causing COVID-19 outbreaks and significant societal/global disruption. Importantly, COVID-19 infection resembles SARS-like complications. However, the lack of knowledge about the underlying genetic mechanisms of COVID-19 warrants the development of prospective control measures. In this study, we employed whole-genome alignment and digital DNA–DNA hybridization analyses to assess genomic linkage between 2019-nCoV and other coronaviruses. To understand the pathogenetic behavior of 2019-nCoV, we compared gene expression datasets of viral infections closest to 2019-nCoV with four COVID-19 clinical presentations followed by functional enrichment of shared dysregulated genes. Potential chemical antagonists were also identified using protein–chemical interaction analysis. Based on phylogram analysis, the 2019-nCoV was found genetically closest to SARS-CoVs. In addition, we identified 562 upregulated and 738 downregulated genes (adj. P ≤ 0.05) with SARS-CoV infection. Among the dysregulated genes, SARS-CoV shared ≤19 upregulated and ≤22 downregulated genes with each of different COVID-19 complications. Notably, upregulation of BCL6 and PFKFB3 genes was common to SARS-CoV, pneumonia and severe acute respiratory syndrome, while they shared CRIP2, NSG1 and TNFRSF21 genes in downregulation. Besides, 14 genes were common to different SARS-CoV comorbidities that might influence COVID-19 disease. We also observed similarities in pathways that can lead to COVID-19 and SARS-CoV diseases. Finally, protein–chemical interactions suggest cyclosporine, resveratrol and quercetin as promising drug candidates against COVID-19 as well as other SARS-like viral infections. The pathogenetic analyses, along with identified biomarkers, signaling pathways and chemical antagonists, could prove useful for novel drug development in the fight against the current global 2019-nCoV pandemic.
- Published
- 2020
- Full Text
- View/download PDF